Ethamolin Ethanolamine Oleate 5% injection Single-Dose Ampules 2 mL x 10/box (RX)

Non-Returnable Item

Ethamolin Ethanolamine Oleate 5% injection is a medication used to treat varicose and spider veins. It contains ethanolamine oleate, a substance that causes irritation and inflammation in the lining of the affected veins, leading to their collapse and eventual disappearance. The solution is injected directly into the vein, usually in multiple sessions, to achieve the desired results. The single-dose ampoules contain 2 mL of the solution, which has a 5% concentration of ethanolamine oleate. These ampoules are used for single-use only and should be discarded after each session.

Ethamolin is a brand name for ethanolamine oleate, which is a sclerosing agent. It is typically used in injection form to treat varicose veins and hemorrhoids.

The mechanism of action of Ethamolin is not fully understood, but it is believed to work by causing inflammation and fibrosis (scarring) of the inner lining of the injected vein or hemorrhoid. This leads to the collapsing of the vein or hemorrhoid, effectively sealing it off and preventing further blood flow.

When injected into a varicose vein, Ethamolin irritates the lining of the vein, causing it to become inflamed and stick together. This helps to close off the vein and prevent blood from flowing through it. Over time, the vein becomes scarred and eventually disappears.

For hemorrhoids, Ethamolin is injected directly into the hemorrhoid, causing inflammation and scarring. This reduces the blood flow to the hemorrhoid, leading to its shrinkage and eventual disappearance.

In summary, the mechanism of action for Ethamolin is to irritate and scar the inner lining of veins and hemorrhoids, leading to the closure and eventual disappearance of the affected area.

Ethamolin Ethanolamine Oleate Prescription Information

ETHAMOLIN Injection is indicated for the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.

ETHAMOLIN is not indicated for the treatment of patients with esophageal varices that have not bled. There is no evidence that treatment of this population decreases the likelihood of bleeding.

Sclerotherapy with ETHAMOLIN has no beneficial effect upon portal hypertension, the cause of esophageal varices, so that recanalization and collateralization may occur, necessitating reinjection.

CONTRAINDICATIONS

ETHAMOLIN Injection should not be administered to subjects with a known hypersensitivity to ethanolamine, oleic acid, or ethanolamine oleate.

WARNINGS

ETHAmOLlN Injection should be used in pregnant women only when clearly needed (see PRECAUTIONS).

The practice of injecting varicosities of the leg with ETHAMOLlN Injection is not supported by adequately-controlled clinical trials. Therefore, such use is not recommended.